Small-Molecule Probes as Pharmacological Tools for the Bone Morphogenetic Protein Signaling Pathway.
Ontology highlight
ABSTRACT: The bone morphogenetic protein (BMP) pathway is highly conserved and plays central roles in health and disease. The quality and quantity of its signaling outputs are regulated at multiple levels, offering pharmacological options for targeted modulation. Both target-centric and phenotypic drug discovery (PDD) approaches were applied to identify small-molecule BMP inhibitors and stimulators. In this Review, we accumulated and systematically classified the different reported chemotypes based on their targets as well as modes-of-action, and herein we illustrate the discovery history of selected candidates. A comprehensive summary of available biochemical, cellular, and in vivo activities is provided for the most relevant BMP modulators, along with recommendations on their preferred use
SUBMITTER: Riege D
PROVIDER: S-EPMC10644459 | biostudies-literature | 2023 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA